Literature DB >> 2413138

Development of antigen-specific cell-mediated immune responses after infection of cynomolgus monkeys (Macaca fascicularis) with Rickettsia tsutsugamushi.

J G MacMillan, R M Rice, T R Jerrells.   

Abstract

Cynomolgus monkeys were evaluated for cellular immune responses after infection with the Karp strain of Rickettsia tsutsugamushi. Antibody and clinical signs of localized and systemic infection were also evaluated. Animals challenged with homologous or heterologous strains at various times after a primary infection were also followed up. Naive monkeys developed eschars, lymphadenopathy, rickettsemia, and elevated body temperatures. Antibody in these animals was IgM followed by IgG. Lymphocyte proliferation and production of gamma-interferon by peripheral blood mononuclear leukocytes also were demonstrated. If challenged six years after the initial infection, clinical signs and cellular responses were indistinguishable from naive animals but an anamnestic IgG antibody response was noted. If challenged eight months after the initial infection, complete resistance was noted, but if challenged at one year, a localized cutaneous lesion developed. The majority of animals infected previously had preexisting lymphocyte activity, a characteristic suggesting long-term immunologic memory that was not protective against rechallenge.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413138     DOI: 10.1093/infdis/152.4.739

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  Unresolved problems related to scrub typhus: a seriously neglected life-threatening disease.

Authors:  Daniel H Paris; Thomas R Shelite; Nicholas P Day; David H Walker
Journal:  Am J Trop Med Hyg       Date:  2013-08       Impact factor: 2.345

2.  Molecular cloning and sequence analysis of the Sta58 major antigen gene of Rickettsia tsutsugamushi: sequence homology and antigenic comparison of Sta58 to the 60-kilodalton family of stress proteins.

Authors:  C K Stover; D P Marana; G A Dasch; E V Oaks
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Scrub typhus vaccine candidate Kp r56 induces humoral and cellular immune responses in cynomolgus monkeys.

Authors:  Suchismita Chattopadhyay; Ju Jiang; Teik-Chye Chan; T Scott Manetz; Chien-Chung Chao; Wei-Mei Ching; Allen L Richards
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Dysregulated Th1 Immune and Vascular Responses in Scrub Typhus Pathogenesis.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2018-02-15       Impact factor: 5.422

5.  A Murine Model of Waning Scrub Typhus Cross-Protection between Heterologous Strains of Orientia tsutsugamushi.

Authors:  Nicole L Mendell; Guang Xu; Thomas R Shelite; Donald H Bouyer; David H Walker
Journal:  Pathogens       Date:  2022-04-26

6.  Conconavalin A-stimulated bovine T-cell supernatants inhibit growth of Cowdria ruminantium in bovine endothelial cells in vitro.

Authors:  S M Mahan; G E Smith; B Byrom
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Susceptibility of Rickettsia tsutsugamushi Gilliam to gamma interferon in cultured mouse cells.

Authors:  B Hanson
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 8.  An Update on Host-Pathogen Interplay and Modulation of Immune Responses during Orientia tsutsugamushi Infection.

Authors:  Fabián E Díaz; Katia Abarca; Alexis M Kalergis
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

9.  Phenotypic characterization of peripheral T cells and their dynamics in scrub typhus patients.

Authors:  Bon-A Cho; Youngho Ko; Yeon-Sook Kim; Sanguk Kim; Myung-Sik Choi; Ik-Sang Kim; Hang-Rae Kim; Nam-Hyuk Cho
Journal:  PLoS Negl Trop Dis       Date:  2012-08-14

Review 10.  Approaches to vaccines against Orientia tsutsugamushi.

Authors:  Gustavo Valbuena; David H Walker
Journal:  Front Cell Infect Microbiol       Date:  2013-01-04       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.